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ABSTRACT
Transplant glomerulopathy (TG) is associated with rapid decline in glomerular filtration rate and poor outcome. We utilized low-density arrays with a novel probabilistic analysis to characterize relationships between gene transcripts and the development of TG in allograft recipients. Retrospective review identified TG in 10.8% of 963 core biopsies from 166 patients; patients with stable function (SF) were studied for comparison. The biopsies were analyzed for expression of 87 genes related to immune function and fibrosis using real-time PCR, and a Bayesian model was generated and validated to predict 
INTRODUCTION
Long-term kidney allograft function continues to improve only modestly, despite dramatic improvements in acute rejection rates and short term patient and graft survivals. 1 In spite of its limitations, measurement of serum creatinine remains the primary monitoring modality following kidney transplantation.
Significant changes in serum creatinine, and/or the development of proteinuria, result in a series of maneuvers to define the many potential etiologies of acute and chronic allograft dysfunction. Allograft biopsy is the "gold-standard" of these maneuvers, although morphologic analysis may not easily distinguish these etiologies. Furthermore, the analysis may be limited in regards to prognostic importance and functional outcome. Thus, identification of biomarkers of allograft failure and the development of tools for their interpretation is of critical interest, both in providing disease detection in a more sensitive and specific fashion, and in allowing sufficient lead time for intervention. Additionally, such markers may allow for risk assessment and medical-regimen tailoring that is personalized to provide optimum outcomes.
Transplant glomerulopathy (TG) is a disease of the kidney allograft initiated by endothelial injury.
Morphologically, there is widening of the subendothelial space with accumulation of debris, mesangial interpositioning, and matrix deposition in the glomerular capillary wall, as well as capillary wall doublecontouring in the absence of immune complex deposition. 2 Electron microscopy may show endothelial cell separation from the glomerular basement membrane prior to light microscopic changes. The etiology of TG is under considerable scrutiny. Prior studies implicated an antibody mediated response [3] [4] [5] , but this has not been consistently demonstrated. 6, 7 Accompanying this lesion may be evidence of chronic injury, including interstitial fibrosis and tubular atrophy (IF/TA), the hallmarks of chronic allograft nephropathy. 8 Clinical presentation often occurs a year or more after transplantation, although in the context of protocol kidney biopsies, light microscopic changes may be seen earlier, with associated proteinuria, hypertension, and a progressive decline in function culminating in graft loss. 9 Importantly, there is no specific effective therapeutic strategy beyond augmentation of immunosuppression. Thus, identifying pathogenic mediators not only for therapeutic purposes but also for early identification may lead to improved outcomes.
In this study, we assess the potential of a novel diagnostic method utilizing custom low density gene expression arrays and machine learning algorithms in an effort to determine the transcriptional features associated with TG and to begin to identify biomarkers that may be indicative of TG. While there has been some research in identifying biomarkers of TG, we have yet to see the evaluation of a systems biology approach to this problem. We focused on transcripts that have been associated with other forms of acute and chronic renal allograft injury in kidney allograft recipients with the intent of evaluating a systems biology modeling approach. Initial data analysis using conventional statistical methods confirmed the proinflammatory state of this lesion. 10 Incorporation of these data utilizing machinelearning software, however, derived statistically significant yet substantially novel associations between individual transcripts. We performed this analysis specifically to assess the potential value of a graphical, hierarchical model of conditional dependence in generating novel hypotheses and providing guidance in patient classification. Moreover, the resulting model provides insight into the probable pathogenesis of TG and a set of potential biomarkers to test and characterize recipients at risk for disease. These results highlight the hypothesis-generating potential of this method by elucidating potential pathways for investigation and the decision-supportive utility of defined, quantitative classification models of disease versus health states. . Positive sera were subsequently tested using specific HLA antigen-coated flow beads (One Lambda, Inc., Canoga Park, CA).
METHODS
Patient selection and evaluation
Biopsy acquisition, preparation, and evaluation
Protocol biopsies were obtained routinely at time of transplantation and at 1, 6, 12, 36, and in some cases 60 months. A portion of the cortex was snap frozen as previously described. 11 The percent cortex was obtained for each sample for validation. For all biopsies this was 75.71±25.52. The remaining portions were fixed in formalin, sectioned, and stained.
All biopsies were evaluated in masked fashion by a single dedicated pathologist and scored using the Banff classification. [12] [13] [14] The diagnosis of TG was based on the presence of glomerular basement membrane duplication and severity scored on the percentage of glomerular peripheral capillary loops involved in affected, non-sclerotic glomeruli. 13 Patients with duplication of the glomerular basement membrane due to recurrent disease were excluded. C4d staining was performed in 43/52 samples using an immunoperoxidase technique.
Quantitative real-time polymerase chain reaction (qPCR)
RNA was extracted and converted to cDNA. 15 cDNA (100ng) was used for qPCR using a Low Density Array (Applied Biosystems Inc., Foster City, CA). 16 Two groups of targets (Table 1) Relative-fold expression data were compared using independent sample Student t-test. A two-tailed p value < 0.05 was considered statistically significant.
Multivariate dependence relationships were also analyzed with FasterAnalytics TM modeling software (Decision Q, Washington, DC), a machine learning software package used to develop graphical models of conditional dependence (Bayesian networks). Machine learned Bayesian networks identify conditional dependence between variables and present this structure to the user in an intuitive, graphical format.
Preliminary modeling included diagnosis (DX; TG or SF), C4d staining grade (Banff C4d; 0, 1, 2, or 3), and each gene of either GP1 or GP2. Quantitative transcript relative-expression data were categorized by distribution into three equal probability density groups. Models were derived in step-wise iterations until the optimal network was identified as determined by cross-validation and qualitative assessment against clinical experience and the literature. To evaluate robustness of the Bayesian models, 10% of the biopsy data were randomly excluded from each dataset in 10 non-overlapping iterations for a 10-fold crossvalidation. 17 To further validate the statistical significance of our findings, we used the directed graph produced by the model and performed a Fisher's exact test to quantify the statistical significance of each arc on a bi-variate basis between the nodes at each end of the arc. Series divided into the same reference ranges as in the Bayesian network and for each pair, a p-value was calculated using Fisher's exact test.
RESULTS
Patient demographics and biopsy characteristics
Patient demographics were matched between the SF and TG patients ( Table 2 ). Patients with TG had higher mean pre-transplant peak PRA and were more likely to have had a prior transplant, but these associations were not statistically significant. However, patients with TG had a significantly higher incidence of post-transplant donor specific antibody (DSA) and graft loss, p<0.05, consistent with prior reported experiences. 5, 8 Mean creatinine at time of biopsy was significantly higher in TG (2.5 ±1.1 mg/dL) compared with SF (1.3 ±0.3 mg/dL) allografts (p<0.001). Significantly more biopsies from TG allografts were obtained for clinical cause (p=0.001; Table 3 ), and, not surprisingly, C4d immunostaining was more often positive in TG biopsies than in SF (p=0.013). By definition, the TG biopsies had a higher chronic glomerulopathy (CG) grade (2.7 ±0.5) than SF biopsies, p<0.001.
Allograft transcriptional profile
Thirty-two transcripts related to immune function were significantly (p<0.05) increased in TG compared with SF, suggesting upregulation of inflammatory pathways involving multiple immune mechanisms ( Figure 1A-G) . Moreover, twenty-five transcripts related to interstitial fibrosis were increased in TG compared with SF (p<0.05).
Graphical Bayesian network of conditional dependence in transcript expression
Machine-learned Bayesian network modeling was used to identify conditional dependence relationships between gene transcript expression data and allograft pathology (TG versus SF as defined in Methods).
GP1 and GP2 expression data were modeled independently and optimized relative to diagnosis. Below we focus on those genes found to be most interdependent on diagnosis within the generated networks.
In GP1 (Figure 2A ), ICAM-1, IL-10, CCL3, and CD86 shared the strongest conditional dependence with diagnosis in the machine-learned model. To further validate our findings, we used the associations identified in the GP1 Bayesian network to perform Fisher exact testing and found the conditional dependence associations to be highly statistically significant, with all associations having a p-value of 0.01 or less. (Table 4 ) Similar to our findings above, multiple additional T-cell function, costimulatory, chemotaxis, and cytokine transcripts were also related to allograft pathology. In SF, relative transcript expression is lower within the network ( Figure 2B) ; conversely, in TG the relative expression of these transcripts is generally higher than in the controls ( Figure 2C ). In this, the unsupervised, machine-learned Bayesian analysis has identified intriguing novel and potentially important relationships among the gene expression profiles and allograft pathology for further exploration and biological validation.
This Bayesian network further enabled investigation of the possible influence of specific, coincident gene expression on allograft pathology. More specifically, classification model GP1 allowed us to estimate the probability of outcome in the study population by using available evidence and without necessitating a full understanding of the underlying biological pathways. Setting the evidence of coincidentally elevated expression of ICAM-1 (≥1.84 fold), IL-10 (≥16.9 fold), and CCL3 (≥3.15 fold) increased the probability of TG to 99.67% as opposed to SF ( Figure 3A) . This served as a demonstration of allograft-outcome probability calculation using transplant-specific gene expression data and an internally cross-validated model.
With increased expression (>8.89 fold) of the costimulatory molecule CD86, multiple related transcripts are also increased as illustrated by the adjusted probability distributions throughout the network ( Figure   3B ). In addition, by increasing only CD86 expression, the probability of TG also increased to 80.61%.
This interactive, evidence-based feature of Bayesian network analysis facilitates elucidation of potentially novel biological pathways.
Comparative transcript and histological Bayesian network probability of allograft pathology
In the Bayesian model of GP2, VCAM-1, MMP-9, MMP-7, and LAMC2 are critically related to pathology ( Figure 4A ). To further validate our findings, we used the associations identified in the GP2
Bayesian network to perform Fisher exact testing and found the conditional dependence associations to be highly statistically significant, with all associations having a p-value of 0.001 or less. (Table 5 ) Coupling histological criteria with transcript expression in the context of a cross-validated classification model provided a powerful predictor of allograft pathology. The probability of TG with a C4d grade of 3 alone is 81.25% ( Figure 4B ; 4D) while, not unexpectedly, the probability of SF with a C4d grade of 0 is 83.9%
( Figure 4D ). However, when coupled to increased expression of VCAM-1 (≥1.96 fold), MMP-9 (≥5.34 fold), MMP-7 (≥2.77 fold), and LAMC2 (>2.19 fold) the probability of TG increased to 99.67% ( Figure   4C ). Furthermore, with increased expression of only LAMC2 (>2.19 fold) and MMP-7 (>2.77 fold), the probability of TG is 95.6%; with decreased expression of LAMC2 (<0.52 fold) and MMP-7 (<1.04 fold), the probability of SF is 99.1% ( Figure 4E ).
Bayesian model validation for transcript network prediction of allograft pathology
Using 10-fold cross-validation analysis, both models for GP1 and GP2 estimated allograft pathology. GP1
estimated TG with an AUC (95% CI) of 0. Of interest is the models ability to predict outcome in sequential biopsies. Thirteen cross-validation models were generated using the same discretization as the overall Bayesian network (Table 6 ). For each training dataset, a single patient's multiple biopsies were removed. The removed patient data were then used to test the new validation model. This cohort of patients with multiple biopsies included 28 biopsies from 13 patients, of which 4 biopsies (2 patients) were diagnosed with TG and 24 biopsies were diagnosed as SF. A comparison of resulting model predictions to pathological findings yields one patient with one biopsy discrepantly identified, while the other biopsy had confirmatory identification; one patient with both biopsies discrepantly identified; two patients with both of their biopsies confirmed as TG; and nine patients with each of their biopsies confirmed as SF.
The analysis of sequential renal graft biopsies yielded consistent transcript expression profiles within GP2. Each biopsy, when classified by the same Bayesian network, exhibited probability of diagnosis similar to its subsequent, matched sample with the exception of two biopsies from one graft, patient 002-003. An additional point is that two of the three SF biopsies that were discrepantly classified as TG by the model were from the same graft, patient 002-014, and were in agreement with each other with a probability greater than 0.84.
DISCUSSION
In this study we attempted to characterize a panel of genes associated with TG using a novel machine- transcriptional data in order to determine the posterior probability of allograft pathology. While there are many analytical technologies available, we have focused on machine learning because of its inherent ability to address high-dimensionality multivariate data. We selected Bayesian networks, specifically, because the graphical models produced are transparent and intuitive, which allows the researcher to more readily identify underlying mechanisms. This approach enhances many classical statistical analyses and has been employed for diagnostic and prognostic applications in oncology 21, 22 and cardiology. 23, 24 When analyzed using Bayesian analysis alone, several conditional relationships become apparent within the transcript profiles. Specifically, ICAM-1, IL-10, CCL3, and CD86 are all conditionally related to outcome when modeling gene expression related to immune function (GP1). Additionally, VCAM-1, MMP-9, MMP-7, and LAMC2 are conditionally related to allograft pathology when analyzed with respect to fibrosis (GP2). As TG is rarely an isolated pathologic lesion, 8 the association of IL-10, CCL3, and CD86, although not histologically evident, may represent transcriptional overlay of cell-mediated inflammatory changes within the allograft. 25 Endothelial activation has been proposed as a mechanism for the pathogenesis of TG, 9 and interestingly, the machine-learned Bayesian network, GP1, associated two endothelial adhesion molecules, ICAM-1 and VCAM-1, directly to allograft pathology. TG is also morphologically characterized by duplication of the basement membrane, and appropriately, laminin 26-29 30 9 TG is believed to be secondary to binding of donor specific antibodies to endothelium with resulting stimulation and recruiting of secondary mediators leading to an inflammatory response. 9 30 This inflammatory response and subsequent tissue injury has been associated with chemokine, adhesion molecule and MMP expression. 26-28 14, 29, 31 Additionally, adhesion molecule expression has been shown to be associated with both chronic disease and stable function in renal transplant recipients. 32 As demonstrated in our model, alteration of chemokine expression has been linked to costimulatatory molecules (CD28,40L,80,86) and IL-10 has been demonstrated to be elevated in allografts with stable function. 26, 33 34-36 Finally, the development of TG and Cd4 expression has also been well characterized. 37 38 9 Thus, our preliminary data suggest that machine-learned Bayesian models may elucidate critical pathways related to the allograft pathology within transcriptional datasets.
While transcriptional analyses of renal transplant biopsies have been extensively reported, 11, 39, 40 this is the first report of an integrated panel with a graphical tool to define conditional relationships and potentially assist the clinician in prediction of transplant-specific diagnosis. As such, the ability to analyze several biomarkers at once offers several advantages over individual endpoints. This allows for the consideration of temporal changes individual biomarker levels vary with time during the disease process. 41 Further, it allows for the capture of feedback loops and inter-biomarker dependencies to improve sensitivity and specificity. Efforts in oncology and HIV have already introduced personalized medicine into clinical reality. 42 In order for a biomarker, or panel of biomarkers, to reach clinical utility as part of a personalized medicine approach, it would ideally meet the following criteria: inexpensive, easy and rapid quantification, detectable early in the course of the disease process, repeatable, and have a high degree of sensitivity and specificity. 43, 44 Based on our preliminary data, we believe that our panel of biomarkers, once prospectively clinically validated, may address these goals for the diagnosis of transplant pathology. PCR based assays, such as used herein, offer the potential of cost effectiveness, repeatability, and rapidity. 45 Additionally, given the relatively long-term survival of renal allografts, prospective application of such models to transplant biopsies may allow for early diagnosis, therapy alterations, and guidance in clinical trials. 2, 46 Admittedly, this study is limited by the current dataset size and disease process. The dataset employed included patients with several different immunosuppressant approaches. While this reduces uniformity, we feel that it enhanced model robustness and favored broad utilization as the strategies used represent current standard practices. TG pathology is evolving, so there are limited treatment options. This limits the ability to judge the effectiveness of a biomarker panel in addressing a clinical disease process;
however, the ability to predict SF as described does offer the ability to affect therapeutic decisions.
Patients quantitatively classified by the network as SF, as opposed to ongoing pathology, may benefit from immunosuppression weaning rather than continuous therapy, which has inherent toxicity, infection, and malignancy risks. Most importantly, the retrospective nature of this study does not allow for robust validation of the predictive models developed from the relationships derived from the transcriptional datasets. This will require additional prospective analysis with models such as described. Additionally, the small number of cases available for analysis renders the disease specific conclusions not definitive and requires further analysis. This is due to a lack of processed biopsies prior to the identification of TG via histologic findings. Therefore, given that many of the relationships uncovered by the model appear to be supported by other investigators, we believe that future analysis would be able to validate the current values are color coded. EDN1  ACTA2  MMP9  BCL2  FASLG  ACTN4  NPHS1  C3  FOXP3  AFAP  NPHS2  CCL2  GATA3  AGRN  PDGFB  CCL3  GNLY  ANGPT2  S100A4  CCL5  GREM1  BMP7  SERPINE1  CCR1  GZMB  CD2AP  SERPINH1  CCR5  HLA-B1/3  CDH1  SMAD3  CD28  ICAM1  CDH3  SMAD7  CD3E  ICOS  COL1A1  SPARC  CD4  IFNG  COL3A1  SPP1  CD40  IL10  COL4A2  TGFB1  CD40LG  IL6  CTGF  THBS1  CD80  IL8  CTNNB1  TIMP1  CD86  MS4A1  FAT  TIMP2  CSF1  PDCD1  FGF2  TIMP3  CTLA4  PRF1  FN1  TIMP4  CX3CL1  SKI  GREM1  TJP1  CX3CR1  TBX21  HSPG2  TNC  CXCL10  TNF  IGF1  VCAM1  CXCL11  LAMC2  VEGF  CXCL9  MMP2  VIM  CXCR3 MMP7 
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